METFORMIN HYDROCHLORIDE clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicentre, Randomized, Double-blind, Placebo-controlled, phase III study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient glycemic control with Metformin and Empagliflozin combination therapy
This study is looking at a new way to treat Type 2 diabetes. It aims to see if adding an extra medication, Pioglitazone, to a common treatment (Metformin and Empagliflozin) helps people manage their blood sugar better. It also checks if this new combination is safe.
For: Type 2 diabetes mellitus (T2DM)Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) Metformin in Patients with Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT) A randomized, 2 x 2 factorial designed, double-blind, placebo controlled study (DANHEART).
This study looks at two different treatments, BiDil and Metformin, for people with long-term heart failure. Researchers want to see if these treatments can reduce serious events like hospital stays, heart transplants, or heart attacks, and improve overall health.
For: Heart failureDenmark - AuthorisedTherapeutic use (Phase IV)
Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial
This study looks at how well different uses of Metformin work for women with Polycystic Ovary Syndrome (PCOS). We're checking its effects on weight, hormones, tummy troubles, and overall health.
For: Polycystic ovary syndromeFinland